KDR and non-small cell lung carcinoma: Based on the functional crosstalk of EGFR and VEGFR-2 through shared common downstream signalling pathways31, it is inferred that the simultaneous inhibition of both EGFR and VEGFR is an effective approach for overcoming the reported resistance in NSCLC.32